Maryam Fouladi
Nationwide Children's Hospital · Pediatric Brain Tumor Consortium · Children's Oncology Group
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Maryam Fouladi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:20 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07291102 · Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk MedulloblastomaNationwide Children's Hospital · not yet recruiting · Medulloblastoma · principal investigator
- Early Ph1NCT06333899 · Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionNationwide Children's Hospital · recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma · principal investigator
- Ph2NCT06161974 · Study of Olutasidenib and Temozolomide in HGGRigel Pharmaceuticals · recruiting · High Grade Glioma, Astrocytoma, Astrocytoma, Grade III · study chair
- Ph2NCT05843253 · Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantNationwide Children's Hospital · recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma · principal investigator
- N/ANCT05839379 · Targeted Pediatric High-Grade Glioma TherapyNationwide Children's Hospital · recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma · study chair
- Ph2NCT05286788 · MEKTOVI® for the Treatment of Pediatric Adamantinomatous CraniopharyngiomaNationwide Children's Hospital · recruiting · Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma · principal investigator
- Ph2NCT05233397 · ACTEMRA® for the Treatment of Pediatric Adamantinomatous CraniopharyngiomaNationwide Children's Hospital · recruiting · Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma · principal investigator
- Ph2NCT05096481 · PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent MedulloblastomaNationwide Children's Hospital · recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma · principal investigator
- Early Ph1NCT04655404 · A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK FusionNationwide Children's Hospital · recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma · study chair
- Ph1NCT03605550 · A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade GliomaNationwide Children's Hospital · active not recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma · study chair
- Ph2NCT01836549 · Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsPediatric Brain Tumor Consortium · terminated · Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II · principal investigator
- Ph2/Ph3NCT01236560 · Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade GliomaNational Cancer Institute (NCI) · completed · Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma · principal investigator
- Ph1NCT01231919 · MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaNational Cancer Institute (NCI) · completed · Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder · principal investigator
- Early Ph1NCT00890786 · A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine GliomasChildren's Hospital Medical Center, Cincinnati · completed · Newly Diagnosed High-Grade Gliomas, Diffuse Intrinsic Pontine Glioma · principal investigator
- Ph1NCT00880282 · Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to TreatmentNational Cancer Institute (NCI) · completed · Unspecified Childhood Solid Tumor, Protocol Specific · principal investigator
- Ph1NCT00572182 · MK0752 in Treating Young Patients With Recurrent or Refractory CNS CancerPediatric Brain Tumor Consortium · terminated · Brain and Central Nervous System Tumors · study chair
- Ph1NCT00217412 · Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaNational Cancer Institute (NCI) · completed · Childhood Acute Promyelocytic Leukemia (M3), Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Burkitt Lymphoma · principal investigator
- Ph1/Ph2NCT00095940 · Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System TumorsNational Cancer Institute (NCI) · completed · Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Ependymoma · principal investigator
- Ph2NCT00070525 · Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem GliomaNational Cancer Institute (NCI) · completed · Childhood High-grade Cerebral Astrocytoma, Childhood Oligodendroglioma, Recurrent Childhood Brain Stem Glioma · principal investigator
- Ph1NCT00053963 · FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaNational Cancer Institute (NCI) · completed · Blastic Phase Chronic Myelogenous Leukemia, Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor · principal investigator
- Ph2NCT00047177 · Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorPediatric Brain Tumor Consortium · completed · Brain and Central Nervous System Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade GliomaR01FD008167 · FDA · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · fiscal years 2025 · $3,218,733 awarded in 2025Same name and institution; not confirmed by an ID
- IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomasR01FD006352 · FDA · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · fiscal years 2019 to 2022 · $250,000 awarded in 2022Same name and institution; not confirmed by an ID
- Pediatric Brain Tumor Consortium (PBTC)UM1CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2014 to 2015 · $2,726,546 awarded in 2015Same name and institution; not confirmed by an ID
- Lapatinib in childhood CNS malignanciesR21CA114937 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2005 to 2006 · $289,289 awarded in 2006Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Pediatric Brain Tumor Consortium (PBTC)U01CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI JAMES Milford BOYETT · fiscal years 1999 to 2013
- COG NCTN Network Group Operations CenterU10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026Named on NCT01236560
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013Named on NCT01236560, NCT00070525
- Children's Oncology Group Phase 1 / Pilot ConsortiumU01CA097452 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI SUSAN M. BLANEY · fiscal years 2002 to 2011
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 12:20 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.J Clin Oncol · 2011129 citationsRCR 3.0
- Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.J Neurooncol · 200662 citationsRCR 1.5
- A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report.Neuro Oncol · 201461 citationsRCR 1.6
- Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study.Neuro Oncol · 202510 citationsRCR 2.4